Students of the year 2010


Parnian Kalbasi Anaraki (MD) IRAN
supervisor: Prof. Dr. Dumler, Nephrology, OE 6840; 
project:  Mesenchymal stem cells in vascular calcification: role for the fibrinolytic and complement Systems
Final exam June 2014. Physician-scientist, Nephrology, MHH; now Klinikum Braunschweig

Claudia Bang GERMANY 
supervisor: Prof. Dr. Thum, IFB-Tx,
project: The role of microRNAs in the crosstalk between cardiac fibroblasts and cardiomyocytes during development of cardiac hypertrophy
Final exam November 2013. IMTTS, MHH; from 2016 Scientific Advisor, MediGate GmbH, Hamburg; since 2017 Clinical Affairs Cconsultant, PROSYSTEM GmbH, Hamburg

Setareh Sadat Banihosseini (MD) IRAN
supervisor:  Dr. Heuser, Haematology and Oncology, OE 6860,    
project: Functional role of MN1 in myeloid neoplasia
Final exam June 2014; research manager in department of family medicine, Providence Health Care, Vancouver, Canada

Anna-Maria Junemann (nee Baumann) GERMANY  
supervisor: Dr. Mühlenhoff, Cellular Chemistry, OE 4330,     
project: Identification and Characterization of Sialic acid specific O-acetyltransferases
Final exam June 2015. Cellular Chemistry, MHH; Boehringer Ingelheim Veterinary Research Center, Hannover; now team leader quality control Microbiology, Schülke & Mayr in Norderstedt (near Hamburg)


Abbas Beh-Pajooh IRAN
supervisor: Tobias Cantz, REBIRTH, OE 8881,   
project: Alternative nuclear reprogramming for the generation of human liver disease-specific iPS cells
Final exam November 2014. Military Service Iran

Budida Ramachandramouli INDIA  
supervisor: Prof. Dr. Behrens, Clinic for Immunology and Rheumatology, OE 6830,
project: Direct and indirect antigen presentation during invasion and latency of HSV-1
Final exam June 2014. Clinic of Immunology and Rheumatology, MHH; now Postdoctoral Scientist at AstraZeneca, Mölndal, Västra Götaland County, Sweden

Himpriya Chopra INDIA  
supervisor: Prof. Dr. O. Pabst, Immunology, OE 5240,   
project: Stroma cells in the modulation of immunity and tolerance in the intestinal immune system
Final exam June 2014. Senior Regional Medical Advisor (Vaccines) at Abbott India Limited, New Delhi Area, India

Arpita Chowdhury INDIA  
supervisor:   Prof. Dr. Theilmeier, Anaestesiology, OE 8050,
project: Role of Fibulin-6 in healthy and diseased myocardium
Final exam June 2014. Anaestesiology, MHH; from 2015 University of Göttingen

Emanuele Gaetano Coci (MD) ITALY  
supervisor: Prof. Dr. Baum, OE 6960, Experimental Hematology,   
project: Development of a novel alpharetroviral vector system for hematopoietic stem cell gene therapy in Wiskott Aldrich Syndrome
Final exam November 2014.

Sebastian Goy GERMANY 
supervisor: Dr. Gerhard, Toxicology, OE 5340,
project: The cell-specific binding of large clostridial glycosyltransferases
Final exam June 2014; LPT Laboratory of Pharmacology and Toxicology, Hamburg; now project manager, Deutsches Zentrum für Infektionsforschung (DZIF), at HZI, Braunschweig


Sayed Shahabuddin Hoseini (MD) IRAN  
supervisor: Prof. Dr. Sauer, Paediatric Haematology, OE 6780,  
project:  Overcoming early exhaustion by chimeric antigen receptor transfer
Final exam November 2014; Pediatrics, Memorial Sloan Kettering Cancer Center, New York; from 2019 Ymabs Therapeutics, New Jersey, USA

Nidhi Jyotsana INDIA  
supervisor:   Dr. Heuser, Haematology and Oncology, OE 6860,
project: MN1 as a therapeutic target in AML
Final exam June 2015; Hematology and Oncology, MHH; now Biomedical Engineering, Vanderbilt University, Nashville, USA


Piyushkumar Kapopara INDIA   
supervisor: Dr. Bavendiek, Cardiology, OE 6880,   
project:  Analysis of vasoprotective and vasoregenerative actions of digitoxin in vivo
Final exam November 2014. Faculty of Medicine, Center for Blood Research, UBC, Vancouver, Canada; now Scientific Specialist (Nanomedicine) at Precision NanoSystems Inc., Vancouver, Canada

Olga Klimenkova (MD) BELARUS 
superrvisor:  Prof. Dr. Welte/ Dr. Skokowa, Molecular Haematopoesis, OE 6790     
project: Pathomechanisms of myelopoiesis and leukemogenesis in patients with severe congenital neutropenia
Final exam November 2013. Molecular Hematopoiesis MHH; Translational Oncology, Innere Medizin II, University Hospital Tübingen; now own business: apparative cosmetics, Hannover

Georgi Manukjan GERMANY
supervisor: Prof. Dr. Schlegelberger/ Dr. Steinemann, Molecular Pathology, OE 5120,  
project: Investigation of the Ets-transcription factor GA-binding protein alpha and its role in leukemogenesis
Final exam November 2014. Human Genetics MHH; now Institute of Experimental Biomedicine, University Hospital Würzburg

Michael Radke GERMANY superviisor: Prof. Dr Manstein, Biophysical Chemistry, OE 4350,   
project:  Energetic coupling in beta cardiac myosin
Final exam November 2013. R&D for synthetic polymers of car tires, Continental, Hannover

Juliane Schott GERMANY 
supervisor:  Prof. Dr. Baum, Experimental Haematology, OE 6960,    
project: Transient delivery of reprogramming factors for generating factor-free iPS cells
Final exam November 2014. Infection, Immunity, Inflammation and Physiological Medicine Programme, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, University College London, London, UK; now Experimental Hematology, MHH

Tran Doan Duy Hai VIETNAM 
supervisor: Prof. Dr. Tamura-Niemann, Physiological Chemistry, OE 4310,   
project: Functional analysis of THOC5, a substrate for tyrosine kinases and a member of mRNA export complex, during myeloid differentiation
Final exam November 2013. Physiological Chemistry, MHH (group leader)

Ching-Fang Wu  (MD) TAIWAN 
supervisor: Prof. Dr. Weiss, Molecular Immunology, HZI   
project: The role of IFN-beta over tumor angiogenesis and tumor metastasis
Final exam November 2013. Nephrology, E-Da Hospital, Kaohsiung, Taiwan

Bi-Huei Yang  TAIWAN
supervisor: Prof. Dr. Hühn, Experimental Immunology, HZI,    
project: Identification and characterization of epigenetic modifications in IL-17-producing T cells
Final exam June 2014. Pediatrics, University of California, San Diego; now scientist, Cancer Immunotherapy, Fate Therapeutics Inc., San Diego, USA